One-page cheat sheet: Surfactant

Surfactant is one of those “small topic, huge yield” concepts that shows up everywhere: newborn respiratory distress, compliance curves, atelectasis, and even why small alveoli don’t collapse into oblivion. Here’s a quick-hit, shareable one-pager you can review in 2 minutes and recall on test day.

---

The one-liner (memorize this)

Surfactant (from type II pneumocytes) decreases surface tension → increases compliance → prevents alveolar collapse (esp at end-expiration) and reduces work of breathing.

---

What it is + where it comes from

Source

• Type II pneumocytes
  • Cuboidal cells in alveoli
  • Also responsible for alveolar repair/regeneration after injury

What it’s made of (high yield)

• Mostly phospholipids (classic: dipalmitoylphosphatidylcholine, DPPC / lecithin)
• Plus surfactant proteins (SP-A, SP-B, SP-C, SP-D)

When it starts (board-relevant timeline)

• Begins production around 20–24 weeks
• Ramps up significantly in the late 3rd trimester
• “Functionally sufficient” is often framed as ~34–36 weeks (varies by source/question stem wording)

---

The physiology you actually need (surface tension, compliance, and stability)

The key relationship: Laplace’s law

For an alveolus: $P = \frac{2T}{r}$

• $P$ = pressure needed to keep the alveolus open
• $T$ = surface tension
• $r$ = radius

Why this matters: small alveoli (low $r$) would require high $P$ to stay open—unless surfactant lowers $T$.

High-yield consequences of surfactant

• ↓ Surface tension ($T$)
• ↓ Collapsing pressure (prevents atelectasis)
• ↑ Lung compliance (easier to inflate)
• ↓ Work of breathing
• ↓ Tendency for fluid to transude into alveoli (helps keep alveoli “dry”)

---

The classic “small vs large alveoli” concept (common trap)

Without surfactant:

• Smaller alveoli have higher $P$ → tend to collapse into larger alveoli

With surfactant:

• Surfactant’s effect is stronger when alveoli are smaller (surfactant molecules become more concentrated as surface area shrinks)
• This stabilizes small alveoli and prevents collapse.

---

Visual/mnemonic device (quick recall)

“SOAP bubble lungs”

Imagine alveoli coated in soap:

• Soap lowers surface tension in bubbles → keeps tiny bubbles from popping
• Surfactant is the lung’s soap

Mnemonic: “SUrface ACTant” → ACTs on surface tension

• SUrfactant ↓ SUrface tension

---

Surfactant vs compliance: how to answer graph questions

Compliance is $C = \Delta V / \Delta P$.

Surfactant increases compliance, so compared with normal:

• The lung inflates more for the same pressure
• On a pressure–volume curve, surfactant shifts the curve up/left (less pressure needed for a given volume)

---

Clinical correlations you’ll see on USMLE (high yield)

Neonatal Respiratory Distress Syndrome (NRDS)

Path: insufficient surfactant (usually prematurity)
Who: premature infants (especially <34 weeks)
Presentation:

• Respiratory distress shortly after birth
• Grunting, nasal flaring, retractions, tachypnea CXR: classically ground-glass appearance + air bronchograms
  Complications: atelectasis, hypoxemia, acidosis

Management (board style):

• Antenatal corticosteroids (e.g., betamethasone) → accelerate type II pneumocyte maturation → ↑ surfactant
• Exogenous surfactant for treatment
• Support with CPAP/ventilation as needed

Transient Tachypnea of the Newborn (TTN) (the “not surfactant” comparison)

• Due to delayed clearance of fetal lung fluid
• Often after C-section
• Usually self-limited within 1–2 days
  Board tip: TTN is about fluid, NRDS is about surfactant.

ARDS (adult respiratory distress syndrome)

Surfactant becomes dysfunctional/inactivated due to diffuse alveolar damage → ↓ compliance (“stiff lungs”).

• Exudative phase: protein-rich edema + hyaline membranes
• Think sepsis, pancreatitis, aspiration, trauma, massive transfusion

---

Type II pneumocyte quick hits (often tested together)

• Type I pneumocytes: gas exchange, thin, cover most alveolar surface area
• Type II pneumocytes: surfactant + regeneration
• Alveolar macrophages (dust cells): phagocytose debris/RBCs (e.g., in CHF you can see hemosiderin-laden macrophages)

---

Super high-yield table: Surfactant facts at a glance

---

Rapid-fire exam bullets (the “last 30 seconds” review)

• Surfactant ↓ $T$ → ↓ $P$ needed to keep alveoli open
• Prevents small alveoli from collapsing into large ones
• Increases compliance → easier inflation → lower work of breathing
• NRDS: prematurity, ground-glass CXR, treat with steroids (prenatal) + surfactant (postnatal)
• ARDS: stiff lungs due to diffuse alveolar damage + surfactant dysfunction